SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599298-22-000125
Filing Date
2022-11-17
Accepted
2022-11-17 16:24:14
Documents
4
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166872022920519.html 3  
1 FORM 3 wf-form3_166872022920519.xml 3 1745
2 ALESSANDRA CESANO POA powerofattorney_alessand.htm EX-24 5184
3 ALESSANDRA CESANO POA PG1 powerofattorney_alessand001.jpg GRAPHIC 274386
4 ALESSANDRA CESANO POA PG2 powerofattorney_alessand002.jpg GRAPHIC 37095
  Complete submission text file 0001599298-22-000125.txt   437745
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 700 BALTIC CIRCLE, SUITE 716 REDWOOD CITY CA 94065
Business Address
Cesano Alessandra (Reporting) CIK: 0001827015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 221398701